We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About NOVIGENIX Stock

Invest in or calculate the value of your shares in NOVIGENIX or other pre-IPO companies through EquityZen's platform.

Get Started

NOVIGENIX Stock (NOEN)

Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.

About NOVIGENIX Stock

Founded

2014

Industries

Software, Data and Analytics, Artificial Intelligence

Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes. The Novigenix proprietary LITOseek platform is optimized for mapping the response of the immune system to onset and progression of disease by integrating patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches, to provide actionable insights and precision solutions for optimization of patient’s therapeutic journey. Our product pipeline currently includes patient stratification solutions in the field of Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and therapy optimization solutions for management of cancer patients. Novigenix provides services to Pharma and Biotech customers by leveraging the proprietary LITOseek data analytics and patient clinical data platform to deliver previously unknown insights into the immune system, and develop ImmunoTranscriptomic solutions with actionable biomarkers for optimization of new therapeutic modalities.

NOVIGENIX Press Mentions

Stay in the know about the latest news on NOVIGENIX

NOVIGENIX Management

Leadership team at NOVIGENIX

Co-Founder and Director Scientific and Clinical Affairs

Laura Ciarloni

Executive Chairman

Brian Hashemi

Locked Features

Join now and verify your accreditation status to gain access to:

  • NOVIGENIX current valuation
  • NOVIGENIX stock price
  • Available deals in NOVIGENIX and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in NOVIGENIX stock?

Accredited investors can buy pre-IPO stock in companies like NOVIGENIX through EquityZen funds. These investments are made available by existing NOVIGENIX shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell NOVIGENIX stock?

Shareholders can sell their NOVIGENIX stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."